Íomhá chlúdaigh

Effect of Monotherapy with Methotrexate, Etanercept and their Combination on the Quality of Life in Children with Early and Late Juvenile Idiopathic Arthritis: A Prospective Study

Background. An important goal of treating patients with juvenile idiopathic arthritis (JIA) is to achieve the best quality of life associated with health. Objective. Our aim was to assess the impact of methotrexate plus etanercept therapy on the quality of life of patients with early and late JIA. M...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Anna N. Fetisova (Údar), Tatyana M. Dvoryakovskaya (Údar), Vladislav V. Chernikov (Údar), Irina V. Vinyarskaya (Údar), Rina V. Denisova (Údar), Margarita A. Soloshenko (Údar), Ksenia В. Isaeva (Údar), Anna V. Mamutova (Údar)
Formáid:	LEABHAR
Foilsithe / Cruthaithe:	"Paediatrician" Publishers LLC, 2018-10-01T00:00:00Z.
Ábhair:	article
Rochtain ar líne:	Connect to this object online.
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate
de réir: Ekaterina Alexeeva, et al.
Foilsithe / Cruthaithe: (2019)

Evaluation of Efficacy and Safety of Etanercept and Etanercept + Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis without Systemic Manifestations
de réir: T. M. Bzarova, et al.
Foilsithe / Cruthaithe: (2016)

Early Prognostic Factors for Remission Achievement at Etanercept Therapy in Patients with Juvenile Idiopatic Arthritis Without Systematic Manifestations: Prospective Cohort Study
de réir: Ekaterina I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2019)

ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH THE JUVENILE IDIOPATHIC ARTHRITIS TREATED BY THE ETANERCEPT
de réir: A. N. Fetisova, et al.
Foilsithe / Cruthaithe: (2014)

PROGNOSTIC FACTORS FOR THE RESPONSE TO TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS: A COHORT STUDY
de réir: Ekaterina I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2018)

Switching to a Second TNF-α Inhibitor in a Patient with Severe Juvenile Polyarthritis: A Clinical Case
de réir: Ekaterina V. Denisova, et al.
Foilsithe / Cruthaithe: (2018)

SUCCESSFUL USE OF ETANERCEPT IN A PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS WITH AN OVERVIEW OF THE PREDICTORS OF A GOOD RESPONSE TO ONGOING THERAPY
de réir: Anna V. Karaseva, et al.
Foilsithe / Cruthaithe: (2017)

COMPARATIVE EFFICACY OF RITUXIMAB AND METHOTREXATE MONOTHERAPY IN STANDARD DOSES IN PATIENTS WITH SEVERE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (PRELIMINARY RESULTS)
de réir: E. I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2012)

Early Predictors of the Response to Adalimumab Therapy in Patients With Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study
de réir: Ekaterina I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2018)

Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review
de réir: Ekaterina I. Alekseeva, et al.
Foilsithe / Cruthaithe: (2019)

Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations
de réir: T. M. Bzarova, et al.
Foilsithe / Cruthaithe: (2015)

USE OF ETANERCEPT IN PATIENTS WITH OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
de réir: Т. М. Bzarova, et al.
Foilsithe / Cruthaithe: (2014)

Efficacy and Safety of Immunization With Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis: Preliminary Results of a Prospective Open-Label Study
de réir: Ekaterina I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2017)

EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
de réir: V. A. Kel'tsev, et al.
Foilsithe / Cruthaithe: (2012)

Immunization With a Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis Without Systemic Manifestations: a Prospective Study
de réir: Ekaterina I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2018)

Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia
de réir: Ekaterina I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2017)

EFFICACY AND SAFETY OF ETANERCEPT TREATMENT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS. THE RESULTS OF AN OPEN PROSPECTIVE STUDY ON THE BASIS OF THE SCIENTIFIC CENTER OF CHILDREN'S HEALTH (MOSCOW)
de réir: Ekaterina I. Alekseeva, et al.
Foilsithe / Cruthaithe: (2016)

The Efficacy of Combination Therapy by Adalimumab with Methotrexate and of Monotherapy by Methotrexate for Children Suffering from Polyarticular Juvenile Idiopathic Arthritis
de réir: V. A. Keltsev, et al.
Foilsithe / Cruthaithe: (2016)

EFFICACY OF ETANERCEPT TREATMENT AS A SECOND TNF α INHIBITOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AND PRIMARY AND SECONDARY INEFFICIENCY OR INTOLERANCE OF INFLIXIMAB
de réir: E. I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2012)

EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
de réir: V. A. Kel'tsev, et al.
Foilsithe / Cruthaithe: (2012)

Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data
de réir: Ekaterina Alexeeva, et al.
Foilsithe / Cruthaithe: (2023)

LONG TERM FOLLOW-UP ON EFFECTIVENESS AND SAFETY OF ETANERCEPT IN JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS
de réir: A. A. Baranov, et al.
Foilsithe / Cruthaithe: (2015)

Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
de réir: Anders Öman, et al.
Foilsithe / Cruthaithe: (2021)

RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF HYPODERMIC METHOTREXATE INJECTIONS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
de réir: E. I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2013)

EXPERIENCE OF METHOTREXATE USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
de réir: T. V. Sleptsova, et al.
Foilsithe / Cruthaithe: (2013)

Experience of Vaccination of a Patient with Systemic Juvenile Idiopathic Arthritis (sJIA) with a 13-Valent Pneumococcal Conjugate Vaccine, prior to the Appointment of Therapy with Tocilizumab, an Anti-IL-6-Receptor Monoclonal Antibody
de réir: Daria D. Vankova, et al.
Foilsithe / Cruthaithe: (2018)

No benefit of the combination therapy etanercept and methotrexate compared to etanercept mono therapy in juvenile idiopathic arthritis - a matched pair analysis
de réir: Schmeling Heinrike, et al.
Foilsithe / Cruthaithe: (2012)

The Experience of Vaccination of a Patient With Juvenile Idiopathic Arthritis With Frequent Respiratory Infections With a Pneumococcal 13-Valent Conjugate Vaccine During Methotrexate Therapy
de réir: Margarita A. Soloshenko, et al.
Foilsithe / Cruthaithe: (2017)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF TREATMENT USING ADALIMUMAB IN COMBINATION WITH METHOTREXATE AND METHOTREXATE MONOTHERAPY IN CHILDREN WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS IN COMBINATION WITH UVEITIS
de réir: V. А. Kel'tsev, et al.
Foilsithe / Cruthaithe: (2014)

EXPERIENCE OF INTRAMUSCULAR METHOTREXATE USE IN A PATIENT WITH EARLY POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
de réir: E. I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2014)

Methotrexate: an effective monotherapy for refractory generalized morphea
de réir: Platsidaki E, et al.
Foilsithe / Cruthaithe: (2017)

Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study
de réir: Ekaterina I. Alexeeva, et al.
Foilsithe / Cruthaithe: (2020)

13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: Clinical Case
de réir: Ekaterina I. Alekseeva, et al.
Foilsithe / Cruthaithe: (2019)

Pneumococcal Vaccination of Patients with Juvenile Idiopathic Arthritis: Review of International Experience
de réir: Margarita A. Soloshenko, et al.
Foilsithe / Cruthaithe: (2017)

Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
de réir: Tiina Levälampi, et al.
Foilsithe / Cruthaithe: (2023)

Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
de réir: Ekaterina Alexeeva, et al.
Foilsithe / Cruthaithe: (2021)

EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
de réir: T. V. Sleptsova, et al.
Foilsithe / Cruthaithe: (2013)

Experience of etanercept treatment in juvenile ankylosing spondyloarthritis
de réir: A. N. Fetisova, et al.
Foilsithe / Cruthaithe: (2013)

Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis
de réir: Majed Khraishi, et al.
Foilsithe / Cruthaithe: (2019)

EFFICACY OF ETANERCEPT IN TREATMENT OF VARIOUS TYPES OF JUVENILE IDIOPATHIC ARTHRITIS
de réir: O. Yu. Konopel'ko, et al.
Foilsithe / Cruthaithe: (2013)